Skip to main content
. 2014 Jun 24;111(3):430–436. doi: 10.1038/bjc.2014.343

Table 2. Efficacy estimates.

 
Number (% 95% CI)
  (n=31)
Best response
 
 Complete response 0 (0)
 Partial response 14 (45; 27.3–64.0)
 Stable disease 14 (45; 27.3–64.0)
 Progressive disease 3 (9.7; 2.0–25.8)
 Overall response rate 14 (45; 27.3–64.0)
 Disease control rate
28 (90; 79.4–100)
Median PFS
10.6 Months (4.8–24.2)
Median OS 20.3 Months (9.1–25.1)

Abbreviations: CI=confidence interval; OS=overall survival; PFS=progression-free survival.